132 related articles for article (PubMed ID: 24705841)
1. [Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment-a case report and review of literature].
Inaishi J; Nogawa S; Mano Y; Yoshizaki T; Okada S
Rinsho Shinkeigaku; 2014; 54(3):238-40. PubMed ID: 24705841
[TBL] [Abstract][Full Text] [Related]
2. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis in a stroke patient taking dabigatran.
Lee VH; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
[No Abstract] [Full Text] [Related]
6. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
[TBL] [Abstract][Full Text] [Related]
7. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
8. Stroke thrombolysis in patients taking dabigatran.
Jayathissa S; Gommans J; Harper P
Intern Med J; 2013 Jul; 43(7):826-8. PubMed ID: 23841763
[TBL] [Abstract][Full Text] [Related]
9. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Pretnar Oblak J; Sabovic M; Frol S
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
[TBL] [Abstract][Full Text] [Related]
11. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
[TBL] [Abstract][Full Text] [Related]
13. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
[TBL] [Abstract][Full Text] [Related]
14. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
Meyer D; Chu F; Derry K; Hailey L
J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
[TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue-type plasminogen activator (rt-PA) therapy in an acute stroke patient taking dabigatran etexilate: a case report and literature review.
Tabata E; Yasaka M; Wakugawa Y; Okada Y
Intern Med; 2014; 53(14):1515-7. PubMed ID: 25030563
[TBL] [Abstract][Full Text] [Related]
16. [Direct oral thrombin inhibitor, "dabigatran"].
Yasaka M
Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
[TBL] [Abstract][Full Text] [Related]
17. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
Ohtani T; Sintoku R; Yajima T; Kaneko N
J Med Case Rep; 2019 Dec; 13(1):390. PubMed ID: 31875786
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
Ohya Y; Makihara N; Wakisaka K; Morita T; Ago T; Kitazono T; Takaba H
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
Brunetti L; Chen C; White J
Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
